MREO — Mereo BioPharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Mereo BioPharma, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	R2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	16.3	23.5	94.3	56.3	45.1
Net Total Receivables	12	4.64	2.23	2.67	3.54
Prepaid Expenses
Total Current Assets	30.4	29.7	99.3	62.1	50.1
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	11.6	1.57	2.53	1.83	1.29
Net Intangible Assets
Total Assets	86.4	62.9	122	84.1	62.5
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	29.9	8.56	9.74	20.2	7.64
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	46.2	77.9	34.3	21.6	13.2
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	40.3	-15	87.7	62.5	49.3
Total Liabilities & Shareholders' Equity	86.4	62.9	122	84.1	62.5
Total Common Shares Outstanding